Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Myelokathexis is a congential disorder of the white blood cells, and Xolremdi, an oral CXCR4 antagonist, is designed to mobilize white blood cells such as neutrophils, lymphocytes and monocytes from the bone marrow into the blood to improve immune deficiencies
Take one tablet first thing in the morning on an empty stomach (after fasting for at least 8 hours) with up to half a glass of plain water (120 ml)
Carly M
Ask about side effect management, protein targets on GLP-1, and meal timing around doses
US$ 26.60
US$ 26.18
US$ 22.46
